Skip to main content
Caplight Logo









Cellexus

Cellexus

Private
DundeeHealthcare & Life Scienceshttps://cellexus.com/

Last Round

Strategic

Apr 2, 2024

Total Funding Raised

$480,000

Company Overview

Cellexus is a life sciences company that researches, develops, and manufactures single-use, airlift bioreactor systems and related technology.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

single-use bioreactorairlift bioreactordisposable bioreactorbioprocessing equipmentsingle-use technologySUTbioreactor manufacturercell culturemicrobial fermentationlow-shear cell culturebacteriophage amplificationairlift technologybioreactor consumablesvaccine productiongene therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cellexus Comparables

Compare Cellexus with similar companies based on industry and business-model similarity.

Cellexus comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Stobbe Group
80%
PBS Biotech
79%
OmniBRx Biotechnologies
79%

Cellexus Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicApr 2, 2024
GrantJun 3, 2021
VC RoundAug 1, 2018

Key People

Founding team and executive leadership

Gavin Hands

CEO, Company Secretary

Executive Team

Cellexus Investors

Notable investors and investment history

Cellexus investors
InvestorRounds
Innovate UKGrant
Scottish Investment Bank (Scottish Enterprise)Grant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 15, 2026

    Monthly visitors increased 48% MoM.

  • Jan 31, 2026

    Monthly visitors grew 42% MoM, reaching 2K.

Cellexus Filings

Explore SEC and related filing metadata, where available.

Cellexus filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Cellexus's valuation, stock price, and market status.

Is Cellexus a public or private company?

Cellexus is a private company.

What is the current stock price of Cellexus?

Cellexus is a private company with no public stock price. No recent secondary market data is available.

How much is Cellexus worth (valuation)?

Valuation information for Cellexus is not publicly available.

Can I buy Cellexus stock?

Cellexus shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Cellexus's last funding round?

Cellexus's most recent funding round was Strategic on April 2, 2024.

Who are the main investors in Cellexus?

Key investors in Cellexus include Innovate UK, Scottish Investment Bank (Scottish Enterprise).

Will Cellexus IPO soon?

No public IPO plans have been announced for Cellexus.

How can I track Cellexus secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cellexus's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDundee
Employee Range4
Year Founded2017
Last FundingApr 2, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?